🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lymphoma Cns

Combination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL NCT07074470NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor), Consolidation therapy with ASC… Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma NCT05209620Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: ICP-022, Pemetrexed Q702 for the Treatment of Patients With Hematologic Malignancies NCT06712810Phase 12 sites📍 Scottsdale📍 Rochester Mayo Clinic · Tests: Axl/Mer/CSF1R Inhibitor Q702, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse NCT07481669Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: TEAM regimen (thiotepa, etoposide, cytarabine and melphalan) Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma NCT05625594Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Aspiration, Biospecimen Collection, Catheterization, CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes, Comput… Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL NCT07185373Phase 2, Phase 315 sites📍 Beijing📍 Beijing📍 Chengdu Huashan Hospital · Tests: Teniposide, Orelabrutinib, MTX, Rituximab (R), Dexamethasone CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study NCT05828628n/a1 site📍 Sutton Royal Marsden NHS Foundation Trust Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL NCT06832267NA1 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies NCT04329728Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Los Angeles AVM Biotechnology Inc · Tests: AVM0703 Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. NCT04627753Phase 21 site📍 Seoul Kim, Seok Jin · Tests: Rituximab, lenalidomide MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma NCT05256641Phase 1, Phase 23 sites📍 Los Angeles📍 Sacramento📍 Oklahoma City Jonsson Comprehensive Cancer Center · Tests: Acalabrutinib B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 NCT05518383Phase 41 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Cyclophosphamide, Cytarabine, Dexamet… [90Y]Y-PTT Endoradiotherapy in CNS Lymphoma Patients NCT06132737Phase 1, Phase 22 sites📍 Munich📍 Essen Pentixapharm AG · Tests: [90Y]Y-PentixaTher The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders NCT06112639NA3 sites📍 Brescia📍 Messina📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: DANCEREX-DTx, Multidimensional dance-based program, Educational Program Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection NCT07555431Phase 21 site📍 Salvador Carlos Brites · Tests: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma NCT05351593Phase 1, Phase 21 site📍 San Francisco James Rubenstein · Tests: Tafasitamab, Lenalidomide A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma NCT06736613Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cerebral Spinal Fluid ctDNA Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury NCT05951777Phase 22 sites📍 Houston📍 San Antonio Hope Biosciences LLC · Tests: Autologous HB-adMSCs, Normal Saline A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies NCT04532203EARLY Phase 11 site📍 Hangzhou Zhejiang University · Tests: CAR-T cells, Ommaya Reservoir Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma NCT05260619Phase 21 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: lenalidomide Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo Chronic CED of TPT for Recurrent Malignant Glioma NCT06666712Phase 11 site📍 New York Jeffrey N. Bruce · Tests: Topotecan Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China NCT07842835n/a3 sites📍 Beijing📍 Shandong📍 Tianjin Xiaohui Ren · Tests: High-dose methotrexate-based therapy, Bruton tyrosine kinase inhibitor-based therapy Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). NCT06213636Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19/CD22-CAR T cells R-PMDT Regimen in Newly Diagnosed PCNSL NCT07604987Phase 21 site📍 Tianjin Zou Dehui · Tests: R-PMDT A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM) NCT04573140Phase 12 sites📍 Washington D.C.📍 Gainesville University of Florida · Tests: Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP li… Cognitive Screening Made Easy for PCPs - Administrative Supplement NCT06928298NA3 sites📍 Austin📍 Austin📍 San Antonio University of Texas at Austin · Tests: RACS app Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) NCT03328078Phase 1, Phase 245 sites📍 Phoenix📍 Phoenix📍 Duarte Curis, Inc. · Tests: Emavusertib, Ibrutinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy